Efficacy and Safety of Solriamfetol on Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea in China: A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial

Hanrong Cheng, Liying Deng, Zili Meng, Wei Zhang, Tao Chen, Rui Chen, Shiyou Tang, Yunhui Lv, Xiaoli Su, Zhifen Liu, Xiaoqing Zhang, Xueyi Wang, Hongjing Mao, Nuofu Zhang, Huan Yu, Jiyang Pan, Yuping Xie, Jiyou Tang, Shankai Yin, Zan Wang, Maoqing Tong, Shuqin Zhan, Chunxue Wang, Bei Wang, Weihua Zhang, Weifeng Mi, Lin Lu

Open source

DOI
10.1007/s40263-025-01232-1
Published
2025-10-23
Container
CNS Drugs
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40263-025-01232-1,
  title = {Efficacy and Safety of Solriamfetol on Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea in China: A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial},
  author = {Hanrong Cheng and Liying Deng and Zili Meng and Wei Zhang and Tao Chen and Rui Chen and Shiyou Tang and Yunhui Lv and Xiaoli Su and Zhifen Liu and Xiaoqing Zhang and Xueyi Wang and Hongjing Mao and Nuofu Zhang and Huan Yu and Jiyang Pan and Yuping Xie and Jiyou Tang and Shankai Yin and Zan Wang and Maoqing Tong and Shuqin Zhan and Chunxue Wang and Bei Wang and Weihua Zhang and Weifeng Mi and Lin Lu},
  year = {2025},
  journal = {CNS Drugs},
  doi = {10.1007/s40263-025-01232-1},
  url = {https://doi.org/10.1007/s40263-025-01232-1}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Solriamfetol on Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea in China: A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial
AU  - Hanrong Cheng
AU  - Liying Deng
AU  - Zili Meng
AU  - Wei Zhang
AU  - Tao Chen
AU  - Rui Chen
AU  - Shiyou Tang
AU  - Yunhui Lv
AU  - Xiaoli Su
AU  - Zhifen Liu
AU  - Xiaoqing Zhang
AU  - Xueyi Wang
AU  - Hongjing Mao
AU  - Nuofu Zhang
AU  - Huan Yu
AU  - Jiyang Pan
AU  - Yuping Xie
AU  - Jiyou Tang
AU  - Shankai Yin
AU  - Zan Wang
AU  - Maoqing Tong
AU  - Shuqin Zhan
AU  - Chunxue Wang
AU  - Bei Wang
AU  - Weihua Zhang
AU  - Weifeng Mi
AU  - Lin Lu
PY  - 2025
JO  - CNS Drugs
DO  - 10.1007/s40263-025-01232-1
UR  - https://doi.org/10.1007/s40263-025-01232-1
ER  - 

APA

Cheng, H., Deng, L., Meng, Z., Zhang, W., Chen, T., Chen, R., Tang, S., Lv, Y., Su, X., Liu, Z., Zhang, X., Wang, X., Mao, H., Zhang, N., Yu, H., Pan, J., Xie, Y., Tang, J., Yin, S., Wang, Z., Tong, M., Zhan, S., Wang, C., Wang, B., Zhang, W., Mi, W., & Lu, L. (2025). Efficacy and Safety of Solriamfetol on Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea in China: A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial. CNS Drugs. https://doi.org/10.1007/s40263-025-01232-1

Source records